Dr. Peter Szlosarek is a Clinical Senior Lecturer and Consultant in Medical Oncology with a PhD in translational cancer medicine from the University of London. His post-doctoral work focuses on the role of the abnormal. Dr. Szlosarek's main clinical interests are in melanoma, lung cancer, and mesothelioma, with a particular emphasis on targeted drugs and metabolic and immunotherapeutic approaches. His areas of expertise include lung cancer, melanoma, and mesothelioma.